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Abstract 
 
Metalloproteinases have been implicated in the pathogenesis of equine laminitis and 
other inflammatory conditions, through their role in the degradation and remodelling 
of the extracellular matrix environment. Matrix metalloproteinases (MMPs) and their 
inhibitors are present in normal equine lamellae, with increased secretion and 
activation of some metalloproteinases reported in horses with laminitis associated 
with systemic inflammation. It is unknown whether these enzymes are involved in 
insulin-induced laminitis, which occurs without overt systemic inflammation. In this 
study, gene expression of MMP-2, MMP-9, MT1-MMP, ADAMTS-4 and TIMP-3 
was determined in the lamellar tissue of normal control horses (n = 4) and horses that 
developed laminitis after 48 h of induced hyperinsulinaemia (n = 4), using 
quantitative Real Time- Polymerase Chain Reaction (qRT-PCR).  Protein 
concentrations of MMP-2 and MMP-9 were also examined using gelatin zymography 
in horses subject to prolonged hyperinsulinaemia for 6 h (n = 4), 12 h (n = 4), 24 h (n 
= 4) and 48 h (n = 4), and in normal control horses (n = 4). The only change in gene 
expression observed was an upregulation of MMP-9 (p < 0.05) in horses that 
developed insulin-induced laminitis (48 h). Zymographical analysis showed an 
increase (p < 0.05) in pro MMP-9 during the acute phase of laminitis (48 h), whereas 
pro MMP-2 was present in similar concentration in the tissue of all horses. Thus, 
MMP-2, MT1-MMP, TIMP-3 and ADAMTS-4 do not appear to play a significant 
role in the pathogenesis of insulin-induced laminitis. The increased expression of 
MMP-9 may be associated with the infiltration of inflammatory leukocytes, or may be 
a direct result of hyperinsulinaemia. The exact role of MMP-9 in basement membrane 
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degradation in laminitis is uncertain as it appears to be present largely in the inactive 
form.  
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1. Introduction 
 
Metalloproteinases and tissue inhibitors of metalloproteinases (TIMPs) are ubiquitous 
and essential components of the extracellular matrix (ECM) with a central role in the 
maintenance of ECM structure through both degradation and remodelling (Woessner, 
1993). The metalloproteinase family includes ADAM proteins (transmembrane 
metalloproteinases with a disintegrin domain), ADAMTS proteins (secreted 
metalloproteinases with thrombospondin repeats) and MMPs (matrix 
metalloproteinases). Metalloproteinases are capable of processing collagen, cytokines 
and growth factors and form an integral part of both pathological and physiological 
processes in the ECM environment (Nagase and Woessner, 1999). Unregulated 
metalloproteinase activity can lead to tissue damage, hence under normal 
circumstances the activity of these enzymes is tightly regulated by TIMPs (Watson 
and Tierney, 1998). A failure of equilibrium between metalloproteinase and TIMP 
activity can result in diseases such as cancer, osteoarthritis (Watson and Tierney, 1998; 
Yoshihara et al., 2000) and possibly laminitis (Coyne et al., 2009; Kyaw-Tanner and 
Pollitt, 2004). 
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Laminitis is an incapacitating locomotor disease of equids that occurs when the 
lamellar dermo-epidermal interface in the hoof is damaged. The condition is initiated 
by a range of factors including alimentary and hormonal disturbances. The 
development of laminitis secondary to hyperinsulinaemia, either as a result of equine 
Cushing’s syndrome (also known as pituitary pars intermedia dysfunction) or equine 
metabolic syndrome (Johnson, 2002), is common (USDA, 2000), yet elements of the 
pathogenesis remain unresolved. Metalloproteinases are purported to play a role in the 
development of naturally-occurring and experimentally-induced laminitis (Coyne et 
al., 2009; Kyaw-Tanner and Pollitt, 2004; Loftus et al., 2009; Pollitt et al., 1998). 
Alimentary carbohydrate (starch or oligofructose) overload (ACO) and black walnut 
extract (BWE) models of laminitis have been associated with evidence of systemic 
inflammation (Galey et al., 1991; Garner et al., 1975; van Eps and Pollitt, 2006), 
while insulin-induced laminitis has not (de Laat et al., 2010).  
 
By cleaving components of the ECM (Nagase and Woessner, 1999) MMPs may break 
down the lamellar basement membrane (BM) during laminitis development, 
precipitating failure of the distal phalangeal attachment apparatus (Pollitt, 2004; 
Pollitt and Visser, 2010). Gelatinases A (MMP-2) and B (MMP-9) are involved in 
laminitis development (Kyaw-Tanner and Pollitt, 2004; Loftus et al., 2006; Pollitt, 
1996) along with the transmembrane MMP, membrane type 1-MMP (MT1-MMP) 
(Kyaw-Tanner et al., 2008), which is responsible for the activation of MMP-2 (Sato et 
al., 1996). More recently, an ADAMTS (4) has also been implicated in laminitis 
pathophysiology (Coyne et al., 2009; Visser, 2008). Metalloproteinase activity in the 
developmental and acute phases of insulin-induced laminitis in horses has not yet 
been described. Based on the lack of evidence of systemic inflammation (de Laat et 
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al., 2010), levels of MMP activity may be different in this form of laminitis. The 
purpose of the current study was to examine MMP-2 and MMP-9 protein 
concentration and the expression of genes coding for MMP-2, MMP-9, MT1-MMP, 
ADAMTS-4 and TIMP-3 in the lamellar tissue of horses in the acute and 
developmental phases of experimentally-induced, hyperinsulinaemic laminitis and 
compare this to healthy control horses. By investigating metalloproteinase gene 
expression and activity in lamellar tissue from horses affected by hyperinsulinaemia, 
further insight into the pathogenesis of insulin-induced laminitis may be gained. 
 
2. Materials and Methods 
 
2.1. Insulin-induced laminitis 
 
Hoof lamellar tissue was collected from control horses (n = 4) and from horses treated 
with a prolonged-euglycaemic hyperinsulinaemic clamp (p-EHC) technique to induce 
hyperinsulinaemia (n = 16). In an initial experiment, eight healthy, adult Standardbred 
racehorses with normal feet and no lameness (based on clinical examination and 
radiography) were allocated at random to either a control or treatment group and 
administered either a combined infusion of insulin (Humulin-R1, 6 mIU/kg bwt/min) 
and 50% dextrose2 (p-EHC), or a balanced electrolyte solution (Hartmanns2, 
0.57ml/kg/h) for up to 48 h. The experiment was continued until the onset of Obel 
grade 2 laminitis (Obel, 1948) in the treated horses (46 ± 2.31 h), at which time the 
horses were euthanased (de Laat et al., 2010). In a separate experiment, twelve 
healthy Standardbred racehorses were randomly allocated to one of three groups (n = 
4) and treated with a p-EHC for either 6, 12 or 24 h, in order to facilitate examination 
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of lamellar tissue during the developmental stages of insulin-induced laminitis. None 
of the horses in the latter experiment developed clinical laminitis. Gelatinase activity 
of MMP-2 and MMP-9 was examined using gelatin zymography in all horses and 
gene expression of MMP-2, MMP-9, MT1-MMP, ADAMTS-4 and TIMP-3 was 
determined using quantitative Real Time- Polymerase Chain Reaction (qRT-PCR) in 
the lamellar tissue of control horses and horses that developed laminitis (48 h). 
 
2.2. Sample collection 
 
Hoof lamellar tissue was collected from the left fore feet of all horses immediately 
upon euthanasia (de Laat et al., 2010). The distal aspect of the limb was disarticulated 
at the metacarpo-phalangeal joint, sectioned with a band saw and then dissected with 
a scalpel to obtain lamellar tissue specimens (5 mm x 5 mm) from the dorsal mid-
section of the hoof. Tissue samples were immediately frozen in liquid nitrogen and 
stored at -80ºC until processed.  
 
2.3. Protein extraction and quantification 
 
Frozen lamellar tissue (100 mg) from each horse was placed in a pre-chilled, heavy-
duty foil envelope, dropped briefly in liquid nitrogen, then removed and immediately 
pulverised on a cold metal block with a hammer. The tissue was quickly removed 
from the envelope and homogenised (OmniTip3) in 1ml of cold Triton-X-100 buffer 
(1.25 ml (0.25%) Triton-X-100, 735 mg (10 mM) CaCl22H2O in 500 ml distilled H2O) 
on ice (5 x 10 s).  The homogenate was then centrifuged at 10,000 x g for 15 min at 
4°C.  The supernatant was removed and stored at -80°C until use. Total protein 
 7 
concentration was determined in quadruplicate with the bicinchoninic acid (BCA) 
protein assay kit (BCA, Pierce4) using bovine serum albumin (BSA) standards (intra-
assay CV = 4.2%). Absorbance at 562 nm was measured on a NanoDrop5 
spectrophotometer. 
 
2.4. Gelatinase analysis: zymography 
 
Twenty micrograms of protein were added (1:2) to sample preparation buffer 
(zymogram sample buffer without β-mercaptoethanol, BioRad6) and incubated at 
room temperature for 10 min. Samples were run on 10% zymogram ready gels with 
gelatin (BioRad6) under non-reducing conditions, for 100 min at 100V. Commercial 
human MMP-2 and MMP-9 standards (Millipore7) were used. Gels were incubated 
twice in renaturation buffer (2.5% Triton X-100) for 30 min on a rotary shaker to 
remove SDS from the gels.  This was followed by incubation overnight at 37°C in 
zymography development buffer (50mM Tris-HCl pH 7.5, 5mM CaCl2). Gels were 
stained for 1 h at room temperature with 0.5% Coomassie R-250 (40% methanol, 10% 
acetic acid, 0.5% Coomassie blue R-250) followed by destaining (40% methanol, 
10% acetic acid) until clear bands were visible against the blue background. Gels 
were scanned using an image editing software (Adobe Photoshop CS48) and analysed 
by densitometry using digital image analysing software (ImageJ v1.389). 
 
2.5. RNA extraction and cDNA synthesis 
 
Total RNA was extracted from 100 mg of frozen lamellar tissue using 1ml of Trizol 
reagent (Invitrogen10) according to the manufacturer’s instructions. RNA 
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concentration was determined by UV spectrophotometry (absorbance; 230 nm). RNA 
samples were treated with RNAse-free DNAse I (Invitrogen10) to eliminate possible 
genomic DNA contamination prior to cDNA synthesis, and then stored at -80°C until 
analysed. One microgram of total RNA was reverse-transcribed to cDNA using the 
Reverse Transcription System (Promega11).  
 
2.6. qRT-PCR and PCR analysis 
 
The qRT-PCR assays for relative quantification of MMP-2, MMP-9, MT1-MMP 
(MMP-14), ADAMTS-4 and TIMP-3 in each lamellar tissue sample were performed 
using a commercial SYBR Green I Master Mix System (Applied Biosystems12).  The 
PCR primer sets for each of the genes (Table 1) were designed from the equine-
specific sequences (GenBank accession no: MMP-2; AJ24331, MMP-9; EF581171, 
MMP-14; EF077282, TIMP-3; AJ243283, ADAMTS-4; EU025848) using primer 
design software (Primer3 v 0.4.013) and synthesized by Integrated DNA 
technologies14. Primer sequences for the house-keeping gene β2-microglobulin were 
adapted from a previous study that showed β2-microglobulin to be a stable house-
keeping gene for equine lamellar tissue during laminitis induction (Visser, 2008), and 
are shown in Table 1. Analysis of the amplification efficiency (E = 10^[–1/slope]) of the 
target and house-keeping genes were determined on serial dilutions of cDNA by qRT-
PCR, with each primer set giving a line with a slope of less than 0.1, and thus 
efficiencies equal to 2, which permits use of the 2-∆CT equation (Visser, 2008). The 
specificity of all primers used in this study was checked via a Blast search (Altschul et 
al., 1997) and the results were confirmed by detection of a single band of the expected 
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PCR product size following 2% agarose gel electrophoresis and sequencing of RT-
PCR products (data not shown).  
 
PCR reactions were performed in 384-well polypropylene plates covered with optical 
caps using an epMotion 5075 robot (Eppendorf15) and were run on an ABI 7900 HT 
Fast Real-Time PCR System (Applied Biosystems12).  The exact primer 
concentrations and PCR conditions were determined during initial optimisation runs.  
Following optimisation experiments, assays of 10 µL reaction volumes were prepared 
comprising an equal concentration of cDNA, 5 µL of 2xSYBR Green Master Mix 
(Applied Biosystems12) and varying amounts of each forward and reverse primer 
(Table 1), as determined by optimisation experiments.  The cycling conditions were as 
follows: 95°C for 10 min, followed by 45 cycles of 15 s at 95°C, and 1 min at 60°C.  
To check the specificity of the amplified products, a melting curve analysis was 
performed immediately after the PCR, in addition to standard agarose gel 
electrophoresis (Sambrook et al., 1989) and sequencing of the PCR products.  All 
samples were amplified on the same plate for every primer pair to ensure equal 
amplification conditions. No-template controls using water instead of cDNA 
templates were also included as negative controls. Each sample was then run in 
triplicate and the results recorded as cycle threshold (CT) values of background-
subtracted, qPCR fluorescence kinetics.  For each sample, CT values for each target 
gene were averaged and relative gene expression was calculated for target genes 
against the reference gene β2-microglobulin, using the 2-∆CT method (Schmittgen and 
Livak, 2008). 
 
2.7. Ethical considerations and statistical analysis 
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The experimental protocol was approved by the animal ethics committee of The 
University of Queensland which ensures compliance with the Animal Welfare Act of 
Queensland (2001) and the Australian Code of Practice for the Care and Use of 
Animals for Scientific Purposes (7th edition 2004). All horses were continuously 
monitored throughout the experimental period by a registered veterinarian. 
Densitometry results were compared between the time-points using one-way analysis 
of variance (ANOVA) and Tukey’s post-hoc test. Wilcoxon t-tests were used to 
compare gene expression between control and treated groups. All data are expressed 
as mean ± se and significance was accepted at p < 0.05. Statistical analyses were 
performed using the R project for statistical computing, version 7.2.7. 
 
3. Results 
 
3.1. Gelatinase expression in lamellar tissue 
 
Pro MMP-2 (72 kDa) was present in the lamellar tissue of all the horses (Fig 1). There 
was no difference in lamellar pro MMP-2 protein concentration between the control 
group and horses that developed laminitis (48 h). However, pro-MMP-2 concentration 
was lower (p < 0.05) in lamellar tissue at 6 h (early in the developmental phase) when 
compared to horses treated with insulin for 24 h and 48 h (Fig 2). There was little to 
no evidence of activated MMP-2 in any of the horses (Fig 1). Pro MMP-9 (92 kDa) 
was present in low concentrations in lamellae from the control group and at early 
time-points (6 h and 12 h) during the developmental phase of insulin-induced 
laminitis (Fig 1). The amount of pro MMP-9 protein was increased (p < 0.05) in 
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lamellar tissue from horses that developed laminitis (48 h) compared to all the other 
groups (Fig 2), but active MMP-9 was not seen (Fig 1). 
 
3.2. Gene expression 
 
MMP-2, MT1-MMP, ADAMTS-4 and TIMP-3 gene expression was observed in 
normal lamellar tissue from control horses (Table 2). Expression of the gene encoding 
for MMP-9 was present in very low levels in control tissue, but was upregulated (p < 
0.05) in the lamellar tissue of horses (48 h) with insulin-induced laminitis (Fig. 3). In 
contrast, there was no change in the gene expression of MMP-2, MT1-MMP, 
ADAMTS-4 or TIMP-3 found in the lamellar tissue between control and laminitic (48 
h) horses (Fig 3).  
 
4. Discussion  
 
Considerable research into the role of metalloproteinases in the pathogenesis of 
alimentary carbohydrate (ACO) and black walnut extract (BWE) induced-laminitis 
has been conducted (Coyne et al., 2009; Kyaw-Tanner and Pollitt, 2004; Loftus et al., 
2009; Mungall and Pollitt, 1999; Pollitt et al., 1998). This study is the first to examine 
metalloproteinase gene expression and activity in lamellar tissue from horses with 
insulin-induced laminitis and contributes new data. The results show that whereas 
genes encoding for MMP-2 and its activator MT1-MMP are expressed in equine 
lamellar tissue, they are not upregulated in Obel grade 2, insulin-induced laminitis. In 
contrast, pro-MMP-9 protein concentration and gene expression is increased in the 
lamellae of horses suffering from insulin-induced laminitis when compared with 
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control tissue. ADAMTS-4 and TIMP-3 gene expression did not differ statistically 
between laminitic and control horses. Hyperinsulinaemic laminitis is associated with 
less systemic inflammation than both the BWE and ACO experimental models which 
may account for the lack of MMP activation seen in the current study (de Laat et al., 
2010; Eades, 2010). 
 
MMP-2 is secreted by basal cells and is present in the lamellar tissue of healthy 
horses (Kyaw-Tanner and Pollitt, 2004). However, its failure to show any increase in 
gene expression, protein concentration or activation in lamellar tissue taken from the 
horses with insulin-induced laminitis indicates that it does not have a significant role 
in the development of this form of the disease. Interestingly, there was a decrease in 
pro-MMP-2 early in the developmental stage (6 h) of laminitis, compared to later 
stages of the developmental phase (24 h) and the acute phase (48 h). This decrease 
might have resulted from increased TIMP activity suppressing MMP-2 secretion. 
However, further studies and a larger sample size would be needed to determine the 
significance, if any, of this finding. Results from previous studies on the gene 
expression of MMP-2 in lamellar tissue during laminitis development have been 
variable. While increased expression of MMP-2 has been shown in horses subject to 
ACO with wheat starch, and during acute flare-ups of naturally-occurring cases of 
chronic laminitis (Loftus et al., 2009), no significant increases were found to occur in 
BWE-treated horses (Loftus et al., 2006), or horses with naturally-occurring, acute or 
non-aggravated chronic laminitis (Loftus et al., 2009). Further work has shown that in 
an oligofructose (OF) model of ACO, activation of MMP-2 occurs at least 12 h after 
the degradation of the BM has commenced, indicating that active MMP-2 seems to be 
produced after key events in the progression of the disease (Visser, 2008). Increased 
 13 
MMP-2 expression and activation might have been seen in laminitic horses, had the 
current study been prolonged beyond 48 h. Indeed, the treated horse with the highest 
concentration of MMP-2 in lamellar tissue (TH1) was euthanased at the latest time-
point (48 h). Zymographical analysis of serum samples taken from control and treated 
horses during the induction of laminitis with starch (Mungall and Pollitt, 1999) 
revealed unchanged circulating concentrations of MMP-2. This experiment also 
ceased at 48 h and whether there was any trend towards an increase in MMP-2 
concentration at the later time-points, as seen in the lamellar samples in the current 
study, was not reported. Regardless, histopathological examination of the horses in 
the current study has shown that lamellar BM damage had commenced by 48 h (de 
Laat et al., 2010), and this occurred in the absence of significantly increased MMP-2 
activity. Thus, the role of MMP-2 in the developmental and acute stages of 
hyperinsulinaemic laminitis is unclear although it may be present at a later stage in 
order to repair the lamellar BM, rather than to effect its degradation.  
 
Similar to the lack of MMP-2 activation seen in this study, was the finding that MT1-
MMP expression remained stable. MT1-MMP is a membrane-bound protein that is 
tethered to the plasma membrane as an active enzyme. Although it has been shown to 
be present in lamellar tissue and at significantly increased levels 48 h after ACO in 
one study (Kyaw-Tanner et al., 2008), its role in the acute and developmental stages 
of insulin-induced laminitis is unclear. The lack of any significant changes in MT1-
MMP gene expression between laminitic and control horses in the current study, has 
been echoed by other studies (Loftus et al., 2009; Visser, 2008).  
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A significant finding of this study was the increase in MMP-9 levels in laminitic 
horses compared with the control group. This elevation was consistent, with 
significant increases in both gene expression and protein concentration of pro MMP-9 
in lamellar tissue. Indeed, increased expression of MMP-9 seems to be common to 
many studies on MMP activity in laminitis, irrespective of the inciting cause (Loftus 
et al., 2009; Pollitt et al., 1998; Visser, 2008). Zymographical analysis shows that it is 
often the inactive form, proMMP-9, that is present in increased concentrations in 
treated animals, whereas the activated form is present at low concentrations (Loftus et 
al., 2006; Loftus et al., 2009; Mungall and Pollitt, 1999; Visser, 2008). The findings 
of the current study were similar. Studies using samples taken during the induction of 
laminitis have found increased pro MMP-9 early in the disease process (Visser, 2008), 
although in the current study, while pro MMP-9 tended to increase throughout the 
developmental stage, this increase was only marked by the acute phase. 
 
MMP-9 is principally derived from leucocytes (Goetzl et al., 1996), and the increased 
presence of MMP-9 in laminitis is possibly associated with neutrophil migration into 
lamellar tissue during the prodromal stages of the disease (Loftus et al., 2009). 
Lamellar pro MMP-9 concentration was positively correlated with myeloperoxidase 
content of the tissue in the recent study by Loftus et al (2009) indicating that 
inflammatory leucocytes played an important role in the increased pro MMP-9 
concentration found in that study. More leucocytes were present in lamellar 
histological sections of horses with insulin-induced laminitis, compared with control 
horses (de Laat et al., 2011), so an increase in MMP-9 activity due to leucocyte 
migration into affected tissue, is plausible.  
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Hyperinsulinaemia is a consequence of insulin resistance (IR) and the human 
Metabolic Syndrome, both of which are seen as pro-inflammatory states. In a recent 
study, human patients with Metabolic Syndrome were found to have increased 
circulating levels of pro MMP-9 that were directly associated with an increased 
concentration of pro-inflammatory mediators (interlukin-6, monocyte chemo-
attractant protein-1, soluble P-selectin) and soluble intercellular adhesion molecule-1, 
further substantiating the relationship between inflammatory states and increased 
MMP-9 activity (Goncalves et al., 2009). However, laminitis was induced in non-
obese horses in the current study which suggests that insulin itself may have been pro-
inflammatory. MMP-9 protein levels (and gelatinolytic activity) are induced by 
insulin in vitro (Fischoeder et al., 2007; Kappert et al., 2008) and hyperinsulinaemia is 
associated with elevated MMP-9 serum levels in humans (Fischoeder et al., 2007). 
Cell culture studies using human monocytic cells (THP-1) identified monocytes as the 
main direct target for insulin-mediated MMP-9 secretion (Kappert et al., 2008). The 
same study showed that there was no direct effect of insulin on MMP-9 synthesis in 
endothelial or vascular smooth muscle cells. Increases in pro MMP-9, when induced 
by insulin in vitro, were dose-dependent and stimulation with an activator of pro 
MMP-9 resulted in further increases in active MMP-9 concentration (Fischoeder et al., 
2007), further implicating hyperinsulinaemia in enhanced MMP-9 synthesis. Insulin 
mediates these increases in MMP-9 via insulin receptor activation and mitogenic 
(mitogen activated protein kinase-kinase) signalling pathways in monocytes, while the 
phosphoinositide 3-kinase pathway, which is typically altered in IR, is not required 
(Fischoeder et al., 2007). This finding may provide an explanation for how 
hyperinsulinaemia could result in increased MMP-9 concentrations in both insulin-
resistant and insulin-sensitive horses. Interestingly, it was shown that insulin had no 
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effect on pro MMP-2 or TIMP-3 expression in these studies (Fischoeder et al., 2007; 
Kappert et al., 2008) which is in keeping with the findings our study. These findings 
may suggest that insulin could be directly responsible for the increased MMP-9 
activity in hyperinsulinaemic horses.  
 
In contrast to other studies (Coyne et al., 2009; Visser, 2008), ADAMTS-4 gene 
expression was not upregulated in laminitic horses in the current study. While there 
was a small (3-fold) increase in ADAMTS-4 concentration, this was less than the 
increases seen in horses with BWE (Coyne et al., 2009), ACO (Coyne et al., 2009; 
Visser, 2008) and acute, naturally-occurring (Coyne et al., 2009) laminitis. 
Furthermore, in a time-point study of OF-induced laminitis (Visser, 2008), an increase 
in ADAMTS-4 expression occurred early in laminitis development and was observed 
at the time when BM degradation was commencing. The reason for the lack of 
significant upregulation of ADAMTS-4 in the acute phase of laminitis in the current 
study is unknown. If ADAMTS-4 is responsible, at least in part, for degradation of the 
BM then we would have expected a larger increase in its gene expression as BM 
breakdown was a histopathological feature of insulin-induced laminitis (de Laat et al., 
2010).  
 
Overall, the results from this study have contributed knowledge about the role of 
metalloproteinases in the developmental and acute stages of insulin-induced laminitis. 
Most importantly, while MMP-2, MT1-MMP, TIMP-3 and ADAMTS-4 are unlikely 
to contribute to the development of insulin-induced laminitis, a role for MMP-9 in the 
pathogenesis of the condition is possible despite its appearance largely in its inactive 
form. Infiltration of inflammatory leukocytes may account for increased MMP-9 or it 
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may be a direct result of hyperinsulinaemia. Further research investigating the 
activation pathways of MMP-9 may be fruitful. 
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Tables 
Table 1: Primer sequences and concentrations (nM) used for quantitative Real Time- 
Polymerase Chain Reaction (qRT-PCR) gene expression of metalloproteinases in 
lamellar tissue from normal (n = 4) and laminitic (n = 4) horses.  
Gene name Forward primer (5'-3') 
Reverse primer 
(5'-3') 
Amplicon size 
(bp) 
Primer 
conc. 
(nM) 
β2- microglobulin  
ACCCAGCAGAGAATGGAAAGC CATCTTCTCTCCATTCTTTAGCAAATC 
101 200 
MMP-2 TTCTTCTTCAAGGACCGGTTCA GAGCTCAGGCCAGAATGTGG 95 300 
MT1-MMP GCCCATCGGCCAGTTCT CCCAATGCTTATCCCCTTTGA 101 200 
MMP-9 CAGGCGTGGGCCAGTTC GTCGCGCGGCAAGTCT 101 200 
ADAMTS-4 TCACCGGCACCATCAATG TGGAGTTCGGTCCCTCGATAC 100 200 
TIMP-3 CCGGACAAGAGCATCATCAA GAAGTTAGTGTCCGAGGGAAGCT 101 200 
 
 
Table 2: qRT-PCR data analysis using cDNA from laminitic (n = 4) and control (n = 
4) horses for MMP-2, MMP-9, MT1-MMP, ADAMTS-4 and TIMP-3 gene 
expression. Relative gene expression is shown for target genes to the reference gene 
β2-microglobulin (2-∆CT) in individual horses.  
Subjects MMP-2 MT1-MMP MMP-9 ADAMTS-4 TIMP-3 
Control 
1 
2 
3 
4 
 
Mean ± se 
 
2.83 
17.1 
1.52 
0.50 
 
5.49 ± 3.38 
 
0.018 
0.005 
0.165 
0.063 
 
0.06 ± 0.04 
 
0.0006 
0.0002 
0.0012 
0.0004 
 
0.0006 ± 0.0002 
 
0.109 
0.051 
0.011 
0.004 
 
0.04 ± 0.02 
 
0.051 
0.031 
0.102 
0.051 
 
0.06 ± 0.02 
 
Insulin 48h 
A 
B 
C 
D 
 
Mean ± se 
 
 
9.2 
2.1 
2.3 
1.0 
 
3.65 ± 1.87 
 
 
0.006 
0.013 
0.165 
0.067 
 
0.06 ± 0.04 
 
 
0.090 
0.016 
0.030 
0.006 
 
0.04 ±0.02 
 
 
0.054 
0.154 
0.058 
0.047 
 
0.08 ± 0.03 
 
 
0.013 
0.019 
0.058 
0.036 
 
0.03 ± 0.01 
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Figures 
 
 
Figure 1: A gelatin zymogram of lamellar tissue samples (n = 20) from the 
developmental (6 h: 6A - D, 12 h: 12A – D, 24 h: 24A – D) and acute (48 h: 48A - D) 
stages of insulin-induced laminitis compared to normal control horses (C1 - 4). Pro 
MMP-9 (92 kDa) is increased in the developmental time-point horses (48 h) when 
compared to all the other groups. Pro MMP-2 (72 kDa) is present in all the horses. 
Active forms of both MMP-2 and MMP-9 are not present. 
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Figure 2: Densitometric analysis of zymogram gels to show the relative intensity of 
pro-MMP-9 (▓) and pro-MMP-2 (▒) staining in five groups of horses (n = 4). Four 
groups of horses were treated with a prolonged-euglycaemic hyperinsulinaemic clamp 
for varying durations: 6 h, 12 h, 24 h and 48 h. The control group (CH) was treated 
with a balanced electrolyte solution for 48 h. The pro-MMP-9 band was stronger (p < 
0.05) in the group treated for 48 h when compared to all the other groups. Pro-MMP-2 
was similar between the groups, except for the 6 h group which was decreased (p < 
0.05) compared to both the 24 h and 48 h groups. 
 24 
 
Figure 3: Quantitative real time PCR analysis for MMP-2, MMP-9, MT1-MMP, 
ADAMTS-4 and TIMP-3 gene expression using cDNA from laminitic (n = 4) and 
control (n = 4) horses. Laminitis was induced with a prolonged euglycaemic 
hyperinsulinaemic clamp technique. The control horses were given a balanced 
electrolyte solution, for 48 h. Fold change in gene expression is shown for the 
laminitic group compared to the control group. 
 
